Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report

Autor:	Miki Koroku, Teppei Omori, Harutaka Kambayashi, Shun Murasugi, Tomoko Kuriyama, Yuichi Ikarashi, Maria Yonezawa, Ken Arimura, Kazunori Karasawa, Norio Hanafusa, Masatoshi Kawana, Katsutoshi Tokushige
Jazyk:	angličtina
Rok vydání:	2022
Předmět:	covid-19 granulocyte and monocyte adsorptive apheresis ulcerative colitis case reports Medicine Diseases of the digestive system. Gastroenterology RC799-869
Zdroj:	Intestinal Research, Vol 20, Iss 1, Pp 150-155 (2022)
Druh dokumentu:	article
ISSN:	1598-9100 2288-1956
DOI:	10.5217/ir.2020.00148
Popis:	Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is now a pandemic. Although several treatment guidelines have been proposed for patients who have both inflammatory bowel disease and COVID-19, immunosuppressive therapy is essentially not recommended, and the treatment options are limited. Even in the COVID-19 pandemic, adjuvant adsorptive granulocyte and monocyte apheresis may safely bring ulcerative colitis (UC) into remission by removing activated myeloid cells without the use of immunosuppressive therapy. Our patient was a 25-year-old Japanese male with UC and COVID-19. This is the first case report of the induction of UC remission with granulocyte and monocyte apheresis treatment for active UC associated with COVID-19.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/8f4ba9c353764d6a8b7be78d76ea3cc8 Zobrazit plný text záznamu View record in DOAJ Plný text ve formátu PDF